Pd44-08 outcomes in Sacral Neuromodulation of Patients With Non-Obstructive Urinary Retention: Effect of Age and Comorbidities

Abstract

p<0.0001) from baseline levels were recorded in IPSS, QoL and peak flow in response to iTind treatment at 6 months, and sexual and urinary continence were preserved (Table 1) CONCLUSIONS: iTind is a well-tolerated, minimally-invasive treatment for BPH-related LUTS offering a rapid recovery and return to daily life, preservation of sexual function and urinary continence as well as a significant improvement of symptoms and urinary flow at 6 months follow up